Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03586999
Title Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Colorado, Denver
Indications

anaplastic large cell lymphoma

peripheral T-cell lymphoma

angioimmunoblastic T-cell lymphoma

liver lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Etoposide + Nivolumab + Prednisone + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST